Population pharmacokinetics of the novel anticancer agent KRN7000.
Crul M, Mathôt RA, Giaccone G, Punt CA, Rosing H, Hillebrand MX, Ando Y, Nishi N, Tanaka H, Schellens JM, Beijnen JH.
Crul M, et al. Among authors: beijnen jh.
Cancer Chemother Pharmacol. 2002 Apr;49(4):287-93. doi: 10.1007/s00280-001-0413-3. Epub 2002 Jan 24.
Cancer Chemother Pharmacol. 2002.
PMID: 11914907
Clinical Trial.